This can be attributed to reduced muscle insulin signaling transduction, which leads to insulin resistance and reduced insulin-stimulated glucose uptake (~30–40%) in individuals with T2DM (Sjöstrand et al., 2000; Middelbeek et al., 2013). The gene discussed is INS; the disease is type 2 diabetes mellitus.